EIF2S1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.154600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.260400E-01
Normal-vs-Stage2
5.450000E-01
Normal-vs-Stage3
8.584600E-01
Normal-vs-Stage4
2.606000E-01
Stage1-vs-Stage2
1.851210E-01
Stage1-vs-Stage3
8.467400E-01
Stage1-vs-Stage4
8.651700E-02
Stage2-vs-Stage3
3.699800E-01
Stage2-vs-Stage4
3.254400E-01
Stage3-vs-Stage4
2.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.048400E-01
Normal-vs-AfricanAmerican
7.554800E-01
Normal-vs-Asian
8.102600E-01
Caucasian-vs-AfricanAmerican
8.493800E-01
Caucasian-vs-Asian
1.807170E-01
AfricanAmerican-vs-Asian
4.750000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.627400E-01
Normal-vs-Female
5.642800E-01
Male-vs-Female
4.194800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.493800E-01
Normal-vs-Age(41-60Yrs)
3.078800E-01
Normal-vs-Age(61-80Yrs)
7.791400E-01
Normal-vs-Age(81-100Yrs)
5.452400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.242400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.404600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.513800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.684100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.470000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.307200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.900600E-01
Normal-vs-Daily Drinker
9.487400E-01
Normal-vs-Weekly Drinker
6.924000E-01
Normal-vs-Occasional Drinker
4.306000E-01
Normal-vs-Social Drinker
5.784400E-01
Non Drinker-vs-Daily Drinker
9.044800E-01
Non Drinker-vs-Weekly Drinker
4.895600E-01
Non Drinker-vs-Occasional Drinker
1.908390E-01
Non Drinker-vs-Social Drinker
3.799800E-01
Daily Drinker-vs-Weekly Drinker
4.688800E-01
Daily Drinker-vs-Occasional Drinker
2.216200E-01
Daily Drinker-vs-Social Drinker
3.982600E-01
Weekly Drinker-vs-Occasional Drinker
9.858800E-01
Weekly Drinker-vs-Social Drinker
8.516800E-01
Occasional Drinker-vs-Social Drinker
7.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.362000E-01
Normal-vs-Grade 2
9.555400E-01
Normal-vs-Grade 3
9.900200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.384020E-02
Grade 1-vs-Grade 3
2.920700E-03
Grade 1-vs-Grade 4
8.362000E-01
Grade 2-vs-Grade 3
1.872220E-01
Grade 2-vs-Grade 4
9.555400E-01
Grade 3-vs-Grade 4
9.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.145800E-01
Normal-vs-NonDiabetic
7.162400E-01
Diabetic-vs-NonDiabetic
9.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.253600E-01
Normal-vs-NoPancreatitis
6.572000E-01
Pancreatitis-vs-NoPancreatitis
9.261700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.573600E-01
Normal-vs-N1
5.281400E-01
N0-vs-N1
1.914020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.150230E-02
Normal-vs-TP53-NonMutant
9.743600E-01
TP53-Mutant-vs-TP53-NonMutant
5.94029999999579E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
